— Organigram (NASDAQ: OGI) reported a net loss from continuing operations of $22.46 million for the fourth quarter of 2019, vs. profit of $18.9 million last year.
— Loss per share was $0.14, compared to earnings of $0.12 per share in the year-ago period
— Fourth-quarter net revenues surged to $16.3 million from $3.2 million last year
— Gross margin, before fair value changes to biological assets and inventories, dropped to $0.7 million from $1.6 million last year
— Adjusted EBITDA was (-)$7.9 million during the three-month period, compared $0.3 million a year earlier
— In the first quarter of 2020, net revenue is expected to increase sequentially on higher retail sales and wholesale revenue
— First-quarter gross margin, before fair value changes to biological assets and inventories, is anticipated to grow sequentially
— Expects the increased efficiencies and economies of scale to reduce cultivation costs in the first quarter, compared to Q4
Most Popular
Infographic: How Cintas (CTAS) performed in Q1 2021
Cintas Corporation (NASDAQ: CTAS) reported first quarter 2021 earnings results today. Revenue was $1.75 billion, down 3.6% year-over-year. Net income rose 19% to $300 million, or $2.78 per share, from
General Mills Q1 results top Wall Street expectations: Infographic
General Mills (NYSE: GIS) reported first-quarter 2020 financial results before the opening bell on Wednesday. The company reported a 9% increase in Q1 revenues to $4.36 billion, beating the Wall
JinkoSolar (JKS) Q2 Earnings: Key financials and quarterly highlights
JinkoSolar Holding Co., Ltd. (NYSE: JKS) reported second quarter 2020 earnings results today. Total revenues increased 22.2% year-over-year to RMB8.45 billion ($1.20 billion), exceeding the company’s guidance of $1.10 billion to $1.18 billion. The growth was
One thought on “Organigram (NASDAQ: OGI) Q4 2019 Earnings Snapshot”
Comments are closed.